Sign inJoin waitlistJoin the waitlist

Teena Bhatla

Director, Division of Hematology/Oncology at NBIMC · Rutgers Health

Credentials: · · ·

History

Rutgers Health
Present
Rutgers Health
Present

NYU Grossman School of Medicine
2011–2012
Pediatrics
Maimonides Medical Center
2008–2011
SAWAI MAN SINGH MED COLL, RAJASTHAN UNIV, JAIPUR, RAJASTHAN
2004–2008

Research

Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
Blood · 2012 · First of 7 authors · 124 citations
MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia
Blood · 2015 · 98 citations
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
Journal of Clinical Oncology · 2023 · 96 citations

William Carroll
18 papers
Elizabeth Raetz
15 papers
Laura Hogan
8 papers
David Teachey
6 papers
PM
Pillai Pallavi Madhusoodhan
6 papers
Stephen Hunger
6 papers
JP
Joanna Pierro
4 papers
Mignon Loh
4 papers
Smita Dandekar
4 papers · 2 as a fellow
Benjamin Lu
3 papers · 3 as a resident
Danielle Bitterman
3 papers
Michael Burke
3 papers

Clinical trials

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Site PI · Recruiting · Phase 2
Children's Oncology Group
2024–2033
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2027
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029